Back to catalog
Peptide Companion
single
Growth Hormone
Vial: 5 mg

GHRP-2 (5 mg Vial)

GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors. Clinical studies predominantly employ once-daily subcutaneous administration to elicit robust pulsatile GH release while minimizing receptor desensitization. This educational protocol presents a practical gradual titration approach with clear insulin-syringe measurements.

Dose
0.1–0.3 mg per injection
Frequency
2–3 times daily
Timing
Morning, post-workout, before bed
Duration
8–12 weeks

Moderate ghrelin activity. Increases appetite. Strong GH release.

Dosing Schedule
WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2100 mcg6 units (0.06 mL)
Weeks 3–4150 mcg9 units (0.09 mL)
Weeks 5–8200 mcg12 units (0.12 mL)
Weeks 9–12200 mcg12 units (0.12 mL)
Weeks 13–16200 mcg12 units (0.12 mL)
Supplies Needed
  • •Peptide Vials (GHRP-2, 5 mg each):
  • •Insulin Syringes (U-100):
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References
  • Domest Anim Endocrinol

    Effects of GHRP-2 on GH release and growth performance in swine (mechanism and receptor activation)

    View source
  • J Clin Endocrinol Metab

    Effects of eight months treatment with graded doses of GHRP-2 in GH-deficient children

    View source
  • Eur J Endocrinol

    Five-day treatment with daily subcutaneous GHRP-2: response attenuation and IGF-I effects in healthy young men

    View source
  • Endocrine

    GH/IGF-1 response to acute and chronic GHRP-2, GHRH 1-44, and their combination in older adults

    View source
  • Am J Men’s Health

    Growth hormone secretagogue treatment in hypogonadal men raises serum IGF-1 levels

    View source
  • Sex Med Rev (PMC)

    The safety and efficacy of growth hormone secretagogues: comprehensive review

    View source
  • Genaxxon Bioscience

    Product Information: Growth Hormone-Releasing Peptide-2 (GHRP-2), technical specifications

    View source
  • Genaxxon Bioscience

    Storage and stability guidelines for research peptides (lyophilized storage recommendations)

    View source
  • Genaxxon Bioscience

    Reconstituted peptide storage: refrigeration and stability considerations

    View source
  • Nurseslabs

    Subcutaneous administration technique: comprehensive nursing guide

    View source
  • Medicine LibreTexts (BCcampus)

    Intradermal and subcutaneous injections: clinical procedures for safer patient care

    View source
  • Chartwell Pennsylvania

    Administering medication via subcutaneous injection: patient teaching guide

    View source
  • Medicine LibreTexts (BCcampus)

    Site rotation and lipodystrophy prevention in subcutaneous injections

    View source

Educational content adapted from peptidedosages.com. Not medical advice.